Wednesday, March 05, 2025 | 06:00 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Jagsonpal Pharmaceuticals standalone net profit rises 97.54% in the September 2020 quarter

Image

Capital Market

Sales rise 34.78% to Rs 56.35 crore

Net profit of Jagsonpal Pharmaceuticals rose 97.54% to Rs 4.01 crore in the quarter ended September 2020 as against Rs 2.03 crore during the previous quarter ended September 2019. Sales rose 34.78% to Rs 56.35 crore in the quarter ended September 2020 as against Rs 41.81 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales56.3541.81 35 OPM %8.596.03 -PBDT5.132.81 83 PBT4.862.54 91 NP4.012.03 98

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 10 2020 | 3:25 PM IST

Explore News